Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Regorafenib
CAS No.: 755037-03-7
Catalog No.: PC-42530Not For Human Use, Lab Use Only.
Regorafenib (BAY 73-4506) is a potent multikinase inhibitor that potently inhibits endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 50 mg | $88 | In stock | |
| 100 mg | $128 | In stock | |
| 200 mg | $178 | In stock | |
| 1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Regorafenib (BAY 73-4506) is a potent multikinase inhibitor that potently inhibits endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
Regorafenib (BAY 73-4506) inhibits VEGFR1/2/3, PDGFRβ, FGFR1, KIT, RET and B-RAF etc.
Regorafenib (BAY 73-4506) exhibits potent dose-dependent TGI in various preclinical human xenograft models in mice; orally active.
| M.Wt | 482.8154 | |
| Formula | C21H15ClF4N4O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
DMSO: ≥ 260 mg/mL |
|
| Chemical Name/SMILES |
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl- |
|
1. Wilhelm SM, et al. Int J Cancer. 2011 Jul 1;129(1):245-55.
2. Mross K, et al. Clin Cancer Res. 2012 May 1;18(9):2658-67.
3. Abou-Elkacem L, et al. Mol Cancer Ther. 2013 Jul;12(7):1322-31.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
